In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Kannada superstar Kiccha Sudeep is busy these days in the promotion of his upcoming film Vikrant
Indian cricket team star batsman Virat Kohli shared a surprising post on social media ahead of th
Former Bihar Chief Minister and RJD chief Lalu Yadav, former Bihar CM Rabri Devi, Bihar Deputy CM
Watches worth crores of Team India all-rounder Hardik Pandya, who returned from Dubai, have been
The 2022 Cannes Film Festival has begun. For the first time this year, India is going to attend t
After Jamtara, Bihar's Nalanda is becoming the hub of cyber fraud, Delhi Police made many arrests
Delhi Police has arrested three people from Nalanda in Bihar on charges of cyber fraud. The names
The central government has announced to recruit 10 lakh posts in the next one and a half years. T
Today is the 21st day of the Russia-Ukraine war. Russia is constantly bombing civilian areas in U
GST Collection: GST collection in May stood at Rs 1.41 lakh crore, 16% less than April
The figures for GST revenue were presented by the Finance Ministry on Wednesday. According to thi
The final match of the Asia Cup 2025 between India and Pakistan will be played in Dubai on Sunday
